STAGE IIA BREAST CANCER
Clinical trials for STAGE IIA BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIA BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo offers hope for elderly breast cancer patients avoiding surgery
Disease control CompletedThis study tested a combination of two drugs, fulvestrant and palbociclib, in older patients with hormone-sensitive breast cancer who either couldn't have surgery or chose not to. The goal was to see if the treatment could control the cancer for at least a year without needing su…
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
9-Day radiation blasts breast cancer with fewer side effects
Disease control CompletedThis study tested a shorter, higher-dose radiation treatment for early-stage breast cancer (stages 0 to IIB) given over just 9 days instead of the usual several weeks. It involved 102 women who had a lumpectomy. The goal was to see if this approach keeps the breast looking good a…
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New combo therapy shows promise in preventing breast cancer return
Disease control CompletedThis study looked at whether shutting down the ovaries (ovarian suppression) combined with hormone therapy (tamoxifen or exemestane) could better prevent breast cancer from coming back in premenopausal women with hormone-sensitive breast cancer. Over 3,000 women who had surgery t…
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC